C-MER MEDICAL (03309) · Company profile · Eqvero

C-MER MEDICAL

03309HKEX

Unit: HKD	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	1.95 bn HKD	1.91 bn HKD	1.92 bn HKD	1.73 bn HKD	1.11 bn HKD
Cost of revenue	1.14 bn HKD	1.1 bn HKD	1.08 bn HKD	1.06 bn HKD	605.77 m HKD
Selling, general and administrative expense	471.38 m HKD	475.98 m HKD	502.73 m HKD	472.12 m HKD	360.56 m HKD
Operating profit after depreciation	142.6 m HKD	128.89 m HKD	124.51 m HKD	4.22 m HKD	8.25 m HKD
Operating profit before depreciation	341.37 m HKD	342.52 m HKD	345.5 m HKD	228.26 m HKD	156.83 m HKD
EBIT	142.6 m HKD	128.89 m HKD	124.51 m HKD	4.22 m HKD	8.25 m HKD
EBITDA	341.37 m HKD	342.52 m HKD	345.5 m HKD	228.26 m HKD	156.83 m HKD
Interest expense	24.34 m HKD	23.66 m HKD	18.12 m HKD	19.66 m HKD	13 m HKD
Profit before tax	155.52 m HKD	-76.22 m HKD	124.27 m HKD	-11.23 m HKD	26.88 m HKD
Income tax expense	44.35 m HKD	32.09 m HKD	37.93 m HKD	35 m HKD	10.65 m HKD
Income before extraordinary items	100.37 m HKD	-135.16 m HKD	62 m HKD	-21.88 m HKD	21.86 m HKD

Quotes are end-of-day data. Content is for research purposes and is not investment advice.